Executive insights: 10 years of transformation at Astellas

  • Facebook
  • Twitter
  • Linkedin
  • Email

The inside view from a life sciences leader

As diseases appear and evolve, so too must drugs, therapies, and the life sciences companies that make them.

We sought the expert view of Shinya Suda, senior vice president of information systems at Astellas, to bring you a series of snapshots of the company's past decade of transformation. Together we explore operations, regulatory affairs, and R&D and get a glimpse into the future of life sciences and drug research and development.

Advances in drug discovery

Watch more episodes

 

Our partnership

Working together delivers healthy outcomes

 

Value for patients

Lead with your purpose and performance will follow

 

Cloud-enabled transformation

How shared data drives sharper decision-making and helps speed drugs to market

 

A connected approach to tackling counterfeit drugs

Addressing a counterfeit drugs market that costs $270bn annually

 

Shaping healthcare with patients' voices

Shinya shares the digital and data levers of patient-first experiences

Learn more about our life science solutions.